Rentiapril

N/A

Report date: 2022/05/18 17:42:01
NME

Base Information

Drug NameRentiapril
Drug Alias Name伦唑普利FentiaprilSA-446DE-040
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanten Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanten
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A